Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease: Review of the evidence

International Congress Series

Volumn 1266, Issue C, 2004, Pages 233-240

  Talbott, Evelyn O ^a   Zborowski, Jeanne V ^a   Boudreaux, Monique Y ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Coronary calcium; Coronary heart disease; Diabetes; Polycystic ovary syndrome; Risk factors

Indexed keywords

EID: 34249793647     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.02.007     Document Type: Article

References (34)

1. L.A. Mattsson Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease Fertil. Steril. 42 1984 579 584
2. R.A. Wild Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 61 1985 946 951
3. R.J. Chang Insulin resistance in nonobese patients with polycystic ovarian disease J. Clin. Endocrinol. Metab. 57 1983 356 359
4. R. Pasquali C-peptide levels in obese patients with polycystic ovaries Horm. Metab. Res. 14 1982 284 287
5. R. Pasquali S. Venturoli Hyperandrogenism, hyperinsulinism and polycystic ovarian disease J. Endocrinol. Invest. 9 1986 531 533
6. E. Dahlgren Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women Acta Obstet. Gynecol. Scand. 71 1992 599 604
7. E. Talbott Coronary heart disease risk factors in women with polycystic ovary syndrome Arterioscler. Thromb. Vasc. Biol. 15 1995 821 826
8. J. Slowinska-Srzednicka The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome J. Endocrinol. Invest. 14 1991 569 575
9. G.S. Conway Risk factors for coronary artery disease in lean obese women with the polycystic ovary syndrome Clin. Endocrinol. (Oxf.) 37 1992 119 125
10. E. Dahlgren Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones Fertil. Steril. 57 1992 505 513
11. S. Franks Polycystic ovary syndrome N. Engl. J. Med. 333 1995 853 861
12. J.A. Eden The polycystic ovary syndrome Aust. N. Z. J. Obstet. Gynaecol. 29 1989 403 416
13. S.S. Yen The polycystic ovary syndrome Clin. Endocrinol. (Oxf.) 12 1980 177 207
14. E. Talbott Adverse lipid coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study J. Clin. Epidemiol. 51 1998 415 422
15. S. Dejager Smaller LDL particle size in women with polycystic ovary syndrome compared to controls Clin. Endocrinol. (Oxf.) 54 2001 455 462
16. A. Dunaif Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174
17. A. Dunaif Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus Am. J. Med. 98 1995 33S 39S
18. A. Dunaif D.T. Finegood Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome J. Clin. Endocrinol. Metab. 81 1996 942 947
19. D.A. Ehrmann Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus J. Clin. Invest. 96 1995 520 527
20. D.A. Ehrmann Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome Diabetes Care 22 1999 141 146
21. R.S. Legro Diabetes prevalence and risk factors in polycystic ovary syndrome Obstet. Gynecol. Clin. North Am. 28 2001 99 109
22. M.A. Birdsall C.M. Farquhar H.D. White Association between polycystic ovary extent of coronary artery disease in women having cardiac catheterization Ann. Intern. Med. 126 1997 32 35
23. D.W. Polson Polycystic ovaries—a common finding in normal women Lancet 1 1988 870 872
24. E.O. Talbott Evidence for association between polycystic ovary and syndrome premature carotid atherosclerosis in middle-aged women Arterioscler. Thromb. Vasc. Biol. 20 2000 2414 2421
25. E. Talbott Metabolic cardiovascular syndrome and its relationship to coronary calcification in women with polycystic ovarian syndrome 3rd International Workshop on Insulin Resistance, New Orleans, LA 2003
26. R.C. Christian Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 88 2003 2562 2568
27. M.T. Magyar Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers Stroke 34 2003 58 63
28. C.C. Kelly Low grade chronic inflammation in women with polycystic ovarian syndrome J. Clin. Endocrinol. Metab. 86 2001 2453 2455
29. E. Talbott The relationship between carotid intima media wall thickness and markers of inflammation and hemostasis in women with polycystic ovary syndrome 4th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, Washington, DC 2003
30. T. Pierpoint Mortality of women with polycystic ovary syndrome at long-term follow-up J. Clin. Epidemiol. 51 1998 581 586
31. S. Wild Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study Clin. Endocrinol. (Oxf.) 52 2000 595 600
32. M.W. Elting Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population Hum. Reprod. 16 2001 556 560
33. D. Cibula Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome Hum. Reprod. 15 2000 785 789
34. W.B. Kannel P.W.F. Wilson Risk factors that attenuate the female coronary disease advantage Arch. Intern. Med. 155 1995 57 61